Institute scientists to undertake rapid COVID-19 research projects

Published: 1 May 2020

The University of Glasgow has been awarded more than £1million by the Scottish Government to look into key areas, including treatments for the virus, underlying health conditions, secondary infections and the long-term effects of social distancing.

Chief Scientist Office logo 700x400

The University of Glasgow has been awarded more than £1million by the Scottish Government to undertake nine crucial COVID-19 research projects, three of which involve Institute scientists.

The funds are part of £5million awarded by the Scottish Government’s Chief Scientist Office, after a rapid research response call aimed at increasing the understanding of the coronavirus pandemic.

Fifteen Scottish universities and research institutions share in the funding for a total of 55 projects, with the University of Glasgow receiving the highest total.

UofG researchers will now begin looking into key areas including treatments for the virus, underlying health conditions, secondary infections and the long-terms effects of social distancing.

Institute of Infection, Immunity & Inflammation staff to receive funding are Dr Janet Scott, Professor Carl Goodyear, and Professor Andrew Roe, the three of whom will work on the following:

  • Dr Janet Scott: Glasgow Early Treatment Arm Favipiravir (GETAFIX): A randomised controlled study of favipiravir as an early treatment arm of ASTERIX in COVID-19 hospitalised patients
  • Prof Carl Goodyear: Viral and Immunological Correlates of Clinical Severity and Response to Anti-Viral Therapy for COVID-19
  • Prof Andrew Roe: Markers of disease: identifying bacterial secondary infections in COVID+ patients

Institute Director Professor Iain McInnes said: “I am delighted that scientists at the University of Glasgow are able to contribute so greatly to this rapid research call by the Scottish Government.

“It is vitally important that we understand as much as we can about this virus, including how we can successfully treat it, and the effect it is having on patients.

"It is also important that we understand the wider impacts of the pandemic, and I am certain our world-leading researchers will be able to provide key insights that will help the global fight against this disease.”

Other UofG projects are:

  • Prof Kevin Blyth: ASTERIX: Adaptive Salvage Treatment based on Endotype-directed anti-virals and Immunomodulation – an NHS framework to enable research and clinical trials
  • Prof RhianTouyz: Hypertension, inhibitors of the renin angiotensin system and COVID-19
  • Prof Colin Berry: Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19) 
  • Dr Christopher Carlin: CARP: COVID-19 Advanced Respiratory Physiological Platform 
  • Dr Katie Robb: Understanding longer term impacts of social distancing and behavioural interventions introduced to prevent the spread of infection in the population
  • Prof Sarah Armstrong: Social and health impacts of COVID-19 suppression in vulnerable groups

Health Secretary Jeane Freeman said: “Scotland is home to some of the most respected researchers and scientists in the world.

COVID-19 is the biggest challenge we have faced in our lifetimes and it is vital that we capture the potential of the extraordinarily strong research base here to contribute to the global efforts to tackle and mitigate the impact of it.  

“I know many academics are already thinking about how their research can be used during this national and international emergency.

"This funding enables universities and research institutions to immediately draw on the very best science and methodologies available to build on our understanding of this virus, develop new treatments, stop infection and support people’s mental and physical health.”

Chief Scientist for Health Professor David Crossman said: “The range of projects – both scientific subject areas and the different research institutions - that are receiving funding will help us understand many aspects of this terrible disease. The projects selected for funding all aim to give results as quickly as possible.

“Scotland is in a strong position to undertake clinical research and the response from universities and research institution to this COVID-19 research call emphatically reinforces that view.”


  • The Rapid Research in COVID-19 funding call was launched by the Scottish Government’s Chief Scientist Office on 25 March 2020.

ali.howard@glasgow.ac.uk or elizabeth.mcmeekin@glasgow.ac.uk / 0141 330 6557 or 0141 330 4831

First published: 1 May 2020